Protective effect of antithrombin III in acute experimental pancreatitis in rats

[1]  M. Dubick,et al.  Biochemical studies in peritoneal fluid from patients with acute pancreatitis , 1987, Digestive Diseases and Sciences.

[2]  M. Steer.  Workshop on experimental pancreatitis , 1985, Digestive Diseases and Sciences.

[3]  K. Heinkel.  Die Ratte als Versuchstier in der experimentellen Pankreasdiagnostik , 1953, Klinische Wochenschrift.

[4]  W. Bechstein,et al.  [Acute pancreatitis]. , 2004, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[5]  H. Redmond,et al.  Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models. , 1989, Gastroenterology.

[6]  K. Bauer,et al.  Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation. , 1989, The American journal of medicine.

[7]  L. Ferrell,et al.  Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. , 1988, Gastroenterology.

[8]  N. Agarwal,et al.  Systemic complications of acute pancreatitis. , 1988, The American journal of gastroenterology.

[9]  W. Steinberg,et al.  Treatment of acute pancreatitis: Comparison of animal and human studies , 1987 .

[10]  H. Vinazzer.  Clinical Use of Antithrombin HI Concentrates , 1987, Vox sanguinis.

[11]  A. Aasen,et al.  Effects on peritoneal proteolysis and hemodynamics of prophylactic infusion with C1 inhibitor in experimental acute pancreatitis. , 1986, Scandinavian journal of gastroenterology.

[12]  N. Bird,et al.  Antiprotease capacity in acute pancreatitis , 1986, The British journal of surgery.

[13]  A. Gabryelewicz,et al.  Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats. , 1986, Hepato-gastroenterology.

[14]  K. Ohlsson,et al.  Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. , 1986, Thrombosis research.

[15]  P. Banks,et al.  Acute pancreatitis. , 1985, Annals of internal medicine.

[16]  K. Ohlsson,et al.  Acute pancreatitis. The correlation between clinical course, protease inhibitors, and complement and kinin activation. , 1984, Scandinavian journal of gastroenterology.

[17]  E. Cooper,et al.  Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. , 1984, American journal of surgery.

[18]  Å. Danielsson,et al.  Mechanism of inactivation of trypsin by antithrombin. , 1982, The Biochemical journal.

[19]  T. Nevalainen,et al.  Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. , 1980, Scandinavian journal of gastroenterology.

[20]  T. Koide.  Isolation and characterization of antithrombin III from human, porcine and rabbit plasma, and rat serum. , 1979, Journal of biochemistry.

[21]  J. Ranson,et al.  The relationship of coagulation factors to clinical complications of acute pancreatitis. , 1977, Surgery.

[22]  E. N. Wardle.  Fibrinogen and albumin catabolism in experimental pancreatitis in the rat. , 1973, Clinical science.

[23]  Poinot.  [On acute pancreatitis]. , 1967, Journal de medecine de Bordeaux et du Sud-Ouest.

[24]  V. Gilsanz,et al.  [Treatment of acute pancreatitis]. , 1980, ANALES RANM.